Sept 12 (Reuters) -

* ZENAS BIOPHARMA ANNOUNCES PRICING OF UPSIZED INITIAL

PUBLIC

OFFERING

* ZENAS BIOPHARMA- PRICING OF ITS UPSIZED IPO OF 13.2

MILLION

SHARES OF ITS COMMON STOCK AT $17 PER SHARE

* ZENAS BIOPHARMA- CO'S COMMON STOCK EXPECTED TO BEGIN

TRADING ON

NASDAQ GLOBAL SELECT MARKET ON SEPTEMBER 13, 2024 UNDER TICKER

SYMBOL "ZBIO"

Source text for Eikon:

Further company coverage: [ ]